Come up with a name for your new list and we'll add to it:
Altheus Therapeutics raised a round of funding on November 17, 2011. Investors include
Economic Development Generating Excellence.
Altheus Therapeutics is developing Zoenasa Oral Controlled Release and Rectal Gel formulations as front-line therapies for the treatment of inflammatory bowel disease (IBD) with the initial focus on u…